116 related articles for article (PubMed ID: 34434895)
1. An Integrative Metabolomic and Network Pharmacology Study Revealing the Regulating Properties of Xihuang Pill That Improves Anlotinib Effects in Lung Cancer.
Li C; Wang Z; Chen W; Cao B; Zhang M; Gu Q; Qi S; Fei X; Shi Y; Li X; Li R; Wang J; Li G
Front Oncol; 2021; 11():697247. PubMed ID: 34434895
[TBL] [Abstract][Full Text] [Related]
2. Modulatory effects of Xihuang Pill on lung cancer treatment by an integrative approach.
Li C; Chen W; Zhang M; Zhang C; Cao B; Dong B; Qi S; Zhang Y; Fei X; Li X; Li R; Wang J; Li G
Biomed Pharmacother; 2020 Oct; 130():110533. PubMed ID: 32739739
[TBL] [Abstract][Full Text] [Related]
3. Xihuang Pill enhances anticancer effect of anlotinib by regulating gut microbiota composition and tumor angiogenesis pathway.
Cao B; Wang S; Li R; Wang Z; Li T; Zhang Y; Dong B; Li Y; Lin M; Li X; Xiao X; Li C; Li G
Biomed Pharmacother; 2022 Jul; 151():113081. PubMed ID: 35605293
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese Medicine Xihuang Wan Inhibited Lewis Lung Carcinoma in a Syngeneic Model, Equivalent to Cytotoxic Chemotherapy, by Altering Multiple Signaling Pathways.
Zhang Z; Wang J; Duan H; Liu D; Zhou X; Lin X; Pang H; Sun M; Zhou T; Hoffman RM; Hu K
In Vivo; 2021; 35(4):2005-2014. PubMed ID: 34182475
[TBL] [Abstract][Full Text] [Related]
5. The modulatory properties of Si Jun Zi Tang enhancing anticancer of gefitinib by an integrating approach.
Li C; Niu M; Wang R; Zhou XW; Dong B; Qi S; Chen W; Zhang M; Shi Y; Li R; Li G
Biomed Pharmacother; 2019 Mar; 111():1132-1140. PubMed ID: 30841426
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer.
Yang Y; Guo Y; Luo H; Wang M; Chen F; Cui H; Chen P; Yin Z; Li L; Dai Y; Zeng J; Zhao J
Front Pharmacol; 2023; 14():1164827. PubMed ID: 37081969
[No Abstract] [Full Text] [Related]
7. Integrating metabolomics and network pharmacology to reveal the mechanisms of Delphinium brunonianum extract against nonalcoholic steatohepatitis.
Zhang K; Yuan Y; Dawa Z; Liu F; Yao Y; Wang M; Zhu C; Lin C
J Ethnopharmacol; 2022 Jul; 293():115268. PubMed ID: 35398502
[TBL] [Abstract][Full Text] [Related]
8. Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells.
Zhang YZ; Yang JY; Wu RX; Fang C; Lu H; Li HC; Li DM; Zuo HL; Ren LP; Liu XY; Xu R; Wen JH; Huang HD; Hong R; Chen QJ
Front Pharmacol; 2021; 12():714628. PubMed ID: 34737698
[TBL] [Abstract][Full Text] [Related]
9. Network Pharmacology-Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer.
Zhao X; Hao J; Chen S
Evid Based Complement Alternat Med; 2020; 2020():6076572. PubMed ID: 32256653
[TBL] [Abstract][Full Text] [Related]
10. A Serum Metabolomic Study Reveals Changes in Metabolites During the Treatment of Lung Cancer-Bearing Mice with Anlotinib.
Pan X; Chen W; Nie M; Liu Y; Xiao Z; Zhang Y; Zhang W; Zou X
Cancer Manag Res; 2021; 13():6055-6063. PubMed ID: 34377024
[TBL] [Abstract][Full Text] [Related]
11. Intervention effect of Qi-Yu-San-Long Decoction on Lewis lung carcinoma in C57BL/6 mice: Insights from UPLC-QTOF/MS-based metabolic profiling.
Wu H; Chen Y; Li Q; Gao Y; Zhang X; Tong J; Zhang Z; Hu J; Wang D; Zeng S; Li Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():23-33. PubMed ID: 30366209
[TBL] [Abstract][Full Text] [Related]
12. Integration of transcriptomics and metabolomics reveals anlotinib-induced cytotoxicity in colon cancer cells.
Jia Z; Zhang Z; Tian Q; Wu H; Xie Y; Li A; Zhang H; Yang Z; Zhang X
Gene; 2021 Jun; 786():145625. PubMed ID: 33798683
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms exploration of Xiaojin Pills on lung cancer based on metabolomics and network pharmacology.
Cao B; Lin J; Wu Z; Liu H; Zhang D; Xu H; Xu R; Han L
J Pharm Pharmacol; 2021 Jul; 73(8):1071-1079. PubMed ID: 33864464
[TBL] [Abstract][Full Text] [Related]
14. Xihuang pill in the treatment of cancer: TCM theories, pharmacological activities, chemical compounds and clinical applications.
Xu HB; Chen XZ; Wang X; Pan J; Yi-Zhuo Z; Zhou CH
J Ethnopharmacol; 2023 Nov; 316():116699. PubMed ID: 37257709
[TBL] [Abstract][Full Text] [Related]
15. Integrated network pharmacology and metabolomics to dissect the combination mechanisms of Bupleurum chinense DC-Paeonia lactiflora Pall herb pair for treating depression.
Li X; Qin XM; Tian JS; Gao XX; Du GH; Zhou YZ
J Ethnopharmacol; 2021 Jan; 264():113281. PubMed ID: 32810624
[TBL] [Abstract][Full Text] [Related]
16. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
[TBL] [Abstract][Full Text] [Related]
17. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
[TBL] [Abstract][Full Text] [Related]
18. Anlotinib suppresses lung adenocarcinoma growth via inhibiting FASN-mediated lipid metabolism.
Shen J; Huang J; Huang Y; Chen Y; Li J; Luo P; Zhang Q; Qiu Y; Wang L; Jiang H; Ma S; Chen X
Ann Transl Med; 2022 Dec; 10(24):1337. PubMed ID: 36660682
[TBL] [Abstract][Full Text] [Related]
19. UHPLC-HRMS-based metabolomic and lipidomic characterization of glioma cells in response to anlotinib.
Shi Y; Li Z; Du Q; Li W; Liu J; Jia Q; Xue L; Zhang X; Sun Z
Sci Rep; 2023 May; 13(1):8044. PubMed ID: 37198251
[TBL] [Abstract][Full Text] [Related]
20. Traditional Chinese Medicine Brucea Javanica Oil Enhances the Efficacy of Anlotinib in a Mouse Model of Liver-Metastasis of Small-cell Lung Cancer.
Peng S; Dong W; Chu Q; Meng J; Yang H; DU Y; Sun YU; Hoffman RM
In Vivo; 2021; 35(3):1437-1441. PubMed ID: 33910820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
